FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of…

Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face

An operations manager finds relief from her depression with the help of psilocybin, the primary psychoactive component of “magic mushrooms.” A veteran conquers his post-traumatic stress disorder through therapy using…

Psychedelics may better treat depression and anxiety symptoms than prescription antidepressants for patients with advanced cancer

In people with advanced cancer, psychedelic drugs like psilocybin, LSD and MDMA may significantly reduce the severity of depression and anxiety symptoms. Roughly 10% of patients with cancer experience anxiety,…